Novel motif:54: Difference between revisions
From FANTOM5_SSTAR
No edit summary |
No edit summary |
||
Line 1: | Line 1: | ||
{ | |||
Latest revision as of 14:47, 9 September 2013
name: | motif54_CGNGTA |
---|
Association to promoter expression in human samples<b>Summary:</b>Significance of the correlation with CAGE expression, human <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
Association to promoter expression in mouse samples
<b>Summary:</b>Significance of the correlation with CAGE expression, mouse <br><b>Analyst:</b> Michiel de Hoon<br><br>link to source dataset <br>data
GREAT analysis results for human
<b>Summary:</b>Genomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon<br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0097039 | protein linear polyubiquitination | 2.276605e-10 |
GO:0016480 | negative regulation of transcription from RNA polymerase III promoter | 2.442369e-10 |
GO:0007549 | dosage compensation | 3.689938e-10 |
GO:0071569 | protein ufmylation | 4.247101e-9 |
GO:0071109 | superior temporal gyrus development | 9.290911e-9 |
GO:0006449 | regulation of translational termination | 1.351161e-8 |
GO:0016032 | viral reproduction | 4.875663e-8 |
GO:0006366 | transcription from RNA polymerase II promoter | 1.092928e-7 |
GO:0060466 | activation of meiosis involved in egg activation | 1.448090e-7 |
GO:0043503 | skeletal muscle fiber adaptation | 2.679839e-7 |
GO:0006414 | translational elongation | 3.005027e-7 |
GO:0006412 | translation | 4.509964e-7 |
GO:0006353 | transcription termination, DNA-dependent | 4.935390e-7 |
GO:0022415 | viral reproductive process | 5.640507e-7 |
GO:0048790 | maintenance of presynaptic active zone structure | 6.556311e-7 |
GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane | 6.556311e-7 |
GO:0042026 | protein refolding | 7.244737e-7 |
GO:0000422 | mitochondrion degradation | 8.930957e-7 |
GO:0051001 | negative regulation of nitric-oxide synthase activity | 1.374165e-6 |
GO:0045905 | positive regulation of translational termination | 1.503845e-6 |
GO:0045901 | positive regulation of translational elongation | 1.503845e-6 |
GO:0006452 | translational frameshifting | 1.503845e-6 |
GO:0046479 | glycosphingolipid catabolic process | 1.630907e-6 |
GO:0033342 | negative regulation of collagen binding | 1.654966e-6 |
GO:0051028 | mRNA transport | 1.955572e-6 |
GO:0006415 | translational termination | 2.081307e-6 |
GO:0019083 | viral transcription | 2.810255e-6 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 3.293488e-6 |
GO:0072126 | positive regulation of glomerular mesangial cell proliferation | 4.927357e-6 |
GO:0071506 | cellular response to mycophenolic acid | 4.927357e-6 |
GO:0008612 | peptidyl-lysine modification to hypusine | 5.257800e-6 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 5.257800e-6 |
GO:0006448 | regulation of translational elongation | 6.818988e-6 |
GO:0010506 | regulation of autophagy | 7.161687e-6 |
GO:0034660 | ncRNA metabolic process | 8.351862e-6 |
GO:0006285 | base-excision repair, AP site formation | 9.144132e-6 |
GO:0006352 | transcription initiation, DNA-dependent | 1.073192e-5 |
GO:0015887 | pantothenate transmembrane transport | 1.145539e-5 |
GO:0015878 | biotin transport | 1.145539e-5 |
GO:0072303 | positive regulation of glomerular metanephric mesangial cell proliferation | 1.217982e-5 |
GO:0010803 | regulation of tumor necrosis factor-mediated signaling pathway | 1.227447e-5 |
GO:0072109 | glomerular mesangium development | 1.295742e-5 |
GO:0001710 | mesodermal cell fate commitment | 1.448850e-5 |
GO:0031619 | homologous chromosome orientation involved in meiotic metaphase I plate congression | 1.449657e-5 |
GO:0008049 | male courtship behavior | 1.449657e-5 |
GO:0043241 | protein complex disassembly | 1.497764e-5 |
GO:0043624 | cellular protein complex disassembly | 1.588960e-5 |
GO:0007029 | endoplasmic reticulum organization | 1.610780e-5 |
GO:0052697 | xenobiotic glucuronidation | 1.624288e-5 |
GO:0070980 | biphenyl catabolic process | 1.624288e-5 |
GO:0052696 | flavonoid glucuronidation | 1.624288e-5 |
GO:0051552 | flavone metabolic process | 1.624288e-5 |
GO:0006789 | bilirubin conjugation | 1.624288e-5 |
GO:0019058 | viral infectious cycle | 1.791591e-5 |
GO:0015074 | DNA integration | 1.868312e-5 |
GO:0045090 | retroviral genome replication | 1.930771e-5 |
GO:0008535 | respiratory chain complex IV assembly | 1.968778e-5 |
GO:0000002 | mitochondrial genome maintenance | 1.984788e-5 |
GO:0022614 | membrane to membrane docking | 2.225507e-5 |
GO:0006313 | transposition, DNA-mediated | 2.440756e-5 |
GO:0008625 | induction of apoptosis via death domain receptors | 2.847547e-5 |
GO:0010999 | regulation of eIF2 alpha phosphorylation by heme | 3.083079e-5 |
GO:0035621 | ER to Golgi ceramide transport | 3.083079e-5 |
GO:0009098 | leucine biosynthetic process | 3.083079e-5 |
GO:0009589 | detection of UV | 3.083079e-5 |
GO:0006550 | isoleucine catabolic process | 3.083079e-5 |
GO:0006348 | chromatin silencing at telomere | 3.112043e-5 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 3.256172e-5 |
GO:0018364 | peptidyl-glutamine methylation | 3.673747e-5 |
GO:0035284 | brain segmentation | 4.528223e-5 |
GO:0014051 | gamma-aminobutyric acid secretion | 4.543062e-5 |
GO:0072110 | glomerular mesangial cell proliferation | 5.025938e-5 |
GO:0045163 | clustering of voltage-gated potassium channels | 5.025938e-5 |
GO:0034470 | ncRNA processing | 5.029255e-5 |
GO:0046785 | microtubule polymerization | 5.348731e-5 |
GO:0060179 | male mating behavior | 5.876979e-5 |
GO:0010509 | polyamine homeostasis | 6.088042e-5 |
GO:2000111 | positive regulation of macrophage apoptosis | 7.807256e-5 |
GO:0032581 | ER-dependent peroxisome organization | 7.856001e-5 |
GO:0030149 | sphingolipid catabolic process | 8.030052e-5 |
GO:0001696 | gastric acid secretion | 8.203885e-5 |
GO:0070389 | chaperone cofactor-dependent protein refolding | 9.410994e-5 |
GO:0015812 | gamma-aminobutyric acid transport | 9.964965e-5 |
GO:0006354 | transcription elongation, DNA-dependent | 1.113886e-4 |
GO:0019377 | glycolipid catabolic process | 1.138363e-4 |
GO:2000725 | regulation of cardiac muscle cell differentiation | 1.144217e-4 |
GO:0070857 | regulation of bile acid biosynthetic process | 1.173491e-4 |
GO:0009294 | DNA mediated transformation | 1.294104e-4 |
GO:0014733 | regulation of skeletal muscle adaptation | 1.298533e-4 |
GO:0019086 | late viral mRNA transcription | 1.298533e-4 |
GO:0007343 | egg activation | 1.393169e-4 |
GO:0035445 | borate transmembrane transport | 1.428100e-4 |
GO:0009401 | phosphoenolpyruvate-dependent sugar phosphotransferase system | 1.428100e-4 |
GO:0048703 | embryonic viscerocranium morphogenesis | 1.453247e-4 |
GO:0042373 | vitamin K metabolic process | 1.457928e-4 |
GO:0046477 | glycosylceramide catabolic process | 1.462099e-4 |
GO:0009804 | coumarin metabolic process | 1.504419e-4 |
GO:0072124 | regulation of glomerular mesangial cell proliferation | 1.621039e-4 |
GO:0050658 | RNA transport | 1.624425e-4 |
GO:0021658 | rhombomere 3 morphogenesis | 1.655492e-4 |
GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 1.656944e-4 |
GO:0046466 | membrane lipid catabolic process | 1.772186e-4 |
GO:0045008 | depyrimidination | 1.779271e-4 |
GO:0046784 | intronless viral mRNA export from host nucleus | 1.845655e-4 |
GO:0006297 | nucleotide-excision repair, DNA gap filling | 1.878474e-4 |
GO:0071385 | cellular response to glucocorticoid stimulus | 1.887095e-4 |
GO:0007181 | transforming growth factor beta receptor complex assembly | 1.963056e-4 |
GO:2000109 | regulation of macrophage apoptosis | 2.335874e-4 |
GO:0046521 | sphingoid catabolic process | 2.618489e-4 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.711096e-4 |
GO:0006403 | RNA localization | 2.735773e-4 |
GO:0016188 | synaptic vesicle maturation | 2.785849e-4 |
GO:0031109 | microtubule polymerization or depolymerization | 3.087284e-4 |
GO:0006499 | N-terminal protein myristoylation | 3.182518e-4 |
GO:0007619 | courtship behavior | 3.243732e-4 |
GO:0045143 | homologous chromosome segregation | 3.243732e-4 |
GO:0006361 | transcription initiation from RNA polymerase I promoter | 3.487882e-4 |
GO:0055005 | ventricular cardiac myofibril development | 3.625593e-4 |
GO:0006406 | mRNA export from nucleus | 3.668247e-4 |
GO:0097045 | phosphatidylserine exposure on blood platelet | 4.241284e-4 |
GO:0072301 | regulation of metanephric glomerular mesangial cell proliferation | 4.280556e-4 |
GO:0016139 | glycoside catabolic process | 4.441111e-4 |
GO:0042254 | ribosome biogenesis | 4.489674e-4 |
GO:0007635 | chemosensory behavior | 4.972158e-4 |
GO:0060431 | primary lung bud formation | 5.549837e-4 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 5.865138e-4 |
GO:0071480 | cellular response to gamma radiation | 5.992302e-4 |
GO:0009107 | lipoate biosynthetic process | 6.289620e-4 |
GO:0070498 | interleukin-1-mediated signaling pathway | 6.409351e-4 |
GO:0060580 | ventral spinal cord interneuron fate determination | 6.532905e-4 |
GO:0003327 | type B pancreatic cell fate commitment | 6.532905e-4 |
GO:0032915 | positive regulation of transforming growth factor beta2 production | 6.552439e-4 |
GO:0032984 | macromolecular complex disassembly | 6.865925e-4 |
GO:0016180 | snRNA processing | 7.003810e-4 |
GO:0043501 | skeletal muscle adaptation | 7.192102e-4 |
GO:0034162 | toll-like receptor 9 signaling pathway | 7.362497e-4 |
GO:0033979 | box H/ACA snoRNA metabolic process | 7.362497e-4 |
GO:0071157 | negative regulation of cell cycle arrest | 7.412176e-4 |
GO:0051320 | S phase | 7.575380e-4 |
GO:0034623 | cellular macromolecular complex disassembly | 7.599712e-4 |
GO:0050975 | sensory perception of touch | 7.796036e-4 |
GO:0000236 | mitotic prometaphase | 7.938679e-4 |
GO:0046601 | positive regulation of centriole replication | 8.171175e-4 |
GO:0051089 | constitutive protein ectodomain proteolysis | 8.171175e-4 |
GO:0043308 | eosinophil degranulation | 8.171175e-4 |
GO:0044342 | type B pancreatic cell proliferation | 8.531917e-4 |
GO:0010918 | positive regulation of mitochondrial membrane potential | 8.531917e-4 |
GO:0033692 | cellular polysaccharide biosynthetic process | 8.881658e-4 |
GO:0030433 | ER-associated protein catabolic process | 9.249217e-4 |
GO:0019885 | antigen processing and presentation of endogenous peptide antigen via MHC class I | 9.478473e-4 |
GO:0010983 | positive regulation of high-density lipoprotein particle clearance | 9.691193e-4 |
GO:0009386 | translational attenuation | 9.691193e-4 |
GO:0000718 | nucleotide-excision repair, DNA damage removal | 9.768071e-4 |
GO:0033233 | regulation of protein sumoylation | 9.984014e-4 |
GO:0046514 | ceramide catabolic process | 1.000858e-3 |
GO:2000987 | positive regulation of behavioral fear response | 1.009604e-3 |
GO:2000727 | positive regulation of cardiac muscle cell differentiation | 1.009604e-3 |
GO:0003185 | sinoatrial valve morphogenesis | 1.009604e-3 |
GO:0003138 | primary heart field specification | 1.009604e-3 |
GO:0035984 | cellular response to trichostatin A | 1.009604e-3 |
GO:0010988 | regulation of low-density lipoprotein particle clearance | 1.020690e-3 |
GO:0000715 | nucleotide-excision repair, DNA damage recognition | 1.020690e-3 |
GO:0006369 | termination of RNA polymerase II transcription | 1.039047e-3 |
GO:0080154 | regulation of fertilization | 1.058302e-3 |
GO:2000438 | negative regulation of monocyte extravasation | 1.058302e-3 |
GO:0035724 | CD24 biosynthetic process | 1.058302e-3 |
GO:0035723 | interleukin-15-mediated signaling pathway | 1.058302e-3 |
GO:0002003 | angiotensin maturation | 1.058302e-3 |
GO:0033057 | multicellular organismal reproductive behavior | 1.084488e-3 |
GO:0042398 | cellular modified amino acid biosynthetic process | 1.096715e-3 |
GO:0000028 | ribosomal small subunit assembly | 1.108290e-3 |
GO:0006363 | termination of RNA polymerase I transcription | 1.130338e-3 |
GO:0090192 | regulation of glomerulus development | 1.202981e-3 |
GO:0060264 | regulation of respiratory burst involved in inflammatory response | 1.211381e-3 |
GO:0071205 | protein localization to juxtaparanode region of axon | 1.230418e-3 |
GO:0015816 | glycine transport | 1.254906e-3 |
GO:2000252 | negative regulation of feeding behavior | 1.262401e-3 |
GO:0006433 | prolyl-tRNA aminoacylation | 1.262401e-3 |
GO:0006768 | biotin metabolic process | 1.317121e-3 |
GO:0009223 | pyrimidine deoxyribonucleotide catabolic process | 1.358069e-3 |
GO:0071312 | cellular response to alkaloid | 1.372175e-3 |
GO:0070086 | ubiquitin-dependent endocytosis | 1.382274e-3 |
GO:0072298 | regulation of metanephric glomerulus development | 1.416767e-3 |
GO:0070327 | thyroid hormone transport | 1.424188e-3 |
GO:0015966 | diadenosine tetraphosphate biosynthetic process | 1.481179e-3 |
GO:0019585 | glucuronate metabolic process | 1.481488e-3 |
GO:0090150 | establishment of protein localization in membrane | 1.543480e-3 |
GO:0000114 | regulation of transcription involved in G1 phase of mitotic cell cycle | 1.581756e-3 |
GO:0035461 | vitamin transmembrane transport | 1.637985e-3 |
GO:0070858 | negative regulation of bile acid biosynthetic process | 1.637985e-3 |
GO:0072111 | cell proliferation involved in kidney development | 1.639522e-3 |
GO:0060263 | regulation of respiratory burst | 1.646487e-3 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.658558e-3 |
GO:0043161 | proteasomal ubiquitin-dependent protein catabolic process | 1.767553e-3 |
GO:0090073 | positive regulation of protein homodimerization activity | 1.831485e-3 |
GO:0000920 | cytokinetic cell separation | 1.886055e-3 |
GO:0015866 | ADP transport | 1.911984e-3 |
GO:0021666 | rhombomere 5 formation | 1.911984e-3 |
GO:0030327 | prenylated protein catabolic process | 1.911984e-3 |
GO:0021660 | rhombomere 3 formation | 1.911984e-3 |
GO:0061001 | regulation of dendritic spine morphogenesis | 1.931446e-3 |
GO:0009264 | deoxyribonucleotide catabolic process | 1.963762e-3 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 1.977818e-3 |
GO:0016073 | snRNA metabolic process | 1.994019e-3 |
GO:0007000 | nucleolus organization | 2.007542e-3 |
GO:0000216 | M/G1 transition of mitotic cell cycle | 2.097644e-3 |
GO:0006298 | mismatch repair | 2.234693e-3 |
GO:0048343 | paraxial mesodermal cell fate commitment | 2.236255e-3 |
GO:0032042 | mitochondrial DNA metabolic process | 2.249108e-3 |
GO:0030644 | cellular chloride ion homeostasis | 2.249108e-3 |
GO:0060025 | regulation of synaptic activity | 2.358005e-3 |
GO:0006677 | glycosylceramide metabolic process | 2.395132e-3 |
GO:0006289 | nucleotide-excision repair | 2.554169e-3 |
GO:0071398 | cellular response to fatty acid | 2.555455e-3 |
GO:2001016 | positive regulation of skeletal muscle cell differentiation | 2.578978e-3 |
GO:0072133 | metanephric mesenchyme morphogenesis | 2.611077e-3 |
GO:0010498 | proteasomal protein catabolic process | 2.624991e-3 |
GO:0043966 | histone H3 acetylation | 2.661552e-3 |
GO:0006626 | protein targeting to mitochondrion | 2.713931e-3 |
GO:0000723 | telomere maintenance | 2.721293e-3 |
GO:0071504 | cellular response to heparin | 2.754213e-3 |
GO:0006401 | RNA catabolic process | 2.772658e-3 |
GO:0010984 | regulation of lipoprotein particle clearance | 2.779999e-3 |
GO:0046398 | UDP-glucuronate metabolic process | 2.779999e-3 |
GO:0019048 | virus-host interaction | 2.892490e-3 |
GO:0031442 | positive regulation of mRNA 3'-end processing | 2.978742e-3 |
GO:0003061 | positive regulation of the force of heart contraction by norepinephrine | 3.001121e-3 |
GO:0061051 | positive regulation of cell growth involved in cardiac muscle cell development | 3.001121e-3 |
GO:0032864 | activation of Cdc42 GTPase activity | 3.004807e-3 |
GO:2000077 | negative regulation of type B pancreatic cell development | 3.012562e-3 |
GO:0018277 | protein deamination | 3.012562e-3 |
GO:0007098 | centrosome cycle | 3.044062e-3 |
GO:0034661 | ncRNA catabolic process | 3.070158e-3 |
GO:0031572 | G2/M transition DNA damage checkpoint | 3.217974e-3 |
GO:0008645 | hexose transport | 3.291582e-3 |
GO:0016137 | glycoside metabolic process | 3.337052e-3 |
GO:2000074 | regulation of type B pancreatic cell development | 3.343551e-3 |
GO:0015931 | nucleobase-containing compound transport | 3.377639e-3 |
GO:0019264 | glycine biosynthetic process from serine | 3.443875e-3 |
GO:0015749 | monosaccharide transport | 3.547081e-3 |
GO:0014745 | negative regulation of muscle adaptation | 3.563720e-3 |
GO:0046501 | protoporphyrinogen IX metabolic process | 3.595701e-3 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 3.643371e-3 |
GO:0043084 | penile erection | 3.647950e-3 |
GO:0033566 | gamma-tubulin complex localization | 3.720344e-3 |
GO:2000009 | negative regulation of protein localization at cell surface | 3.729022e-3 |
GO:0015761 | mannose transport | 3.729022e-3 |
GO:0006268 | DNA unwinding involved in replication | 3.812519e-3 |
GO:0051354 | negative regulation of oxidoreductase activity | 3.821861e-3 |
GO:0032727 | positive regulation of interferon-alpha production | 3.943448e-3 |
GO:0006244 | pyrimidine nucleotide catabolic process | 3.973322e-3 |
GO:0006600 | creatine metabolic process | 3.974731e-3 |
GO:0071503 | response to heparin | 4.034086e-3 |
GO:0051182 | coenzyme transport | 4.164070e-3 |
GO:0015959 | diadenosine polyphosphate metabolic process | 4.167926e-3 |
GO:0006479 | protein methylation | 4.183554e-3 |
GO:0019883 | antigen processing and presentation of endogenous antigen | 4.240633e-3 |
GO:0010826 | negative regulation of centrosome duplication | 4.289618e-3 |
GO:0010477 | response to sulfur dioxide | 4.289618e-3 |
GO:0002457 | T cell antigen processing and presentation | 4.289618e-3 |
GO:0000088 | mitotic prophase | 4.289618e-3 |
GO:0090307 | spindle assembly involved in mitosis | 4.340522e-3 |
GO:0060821 | inactivation of X chromosome by DNA methylation | 4.379482e-3 |
GO:0010986 | positive regulation of lipoprotein particle clearance | 4.379482e-3 |
GO:0006054 | N-acetylneuraminate metabolic process | 4.379482e-3 |
GO:0018342 | protein prenylation | 4.527471e-3 |
GO:0007099 | centriole replication | 4.527471e-3 |
GO:0007192 | activation of adenylate cyclase activity by serotonin receptor signaling pathway | 4.544256e-3 |
GO:0032200 | telomere organization | 4.681271e-3 |
GO:2000822 | regulation of behavioral fear response | 4.732281e-3 |
GO:0006014 | D-ribose metabolic process | 4.816713e-3 |
GO:0016075 | rRNA catabolic process | 4.904707e-3 |
GO:0006405 | RNA export from nucleus | 5.065427e-3 |
GO:0045653 | negative regulation of megakaryocyte differentiation | 5.069280e-3 |
GO:0071455 | cellular response to hyperoxia | 5.069280e-3 |
GO:0051318 | G1 phase | 5.119625e-3 |
GO:0060154 | cellular process regulating host cell cycle in response to virus | 5.171650e-3 |
GO:0043060 | meiotic metaphase I plate congression | 5.494971e-3 |
GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway | 5.494971e-3 |
GO:0000084 | S phase of mitotic cell cycle | 5.565309e-3 |
GO:0060266 | negative regulation of respiratory burst involved in inflammatory response | 5.607296e-3 |
GO:0021986 | habenula development | 5.660576e-3 |
GO:0060236 | regulation of mitotic spindle organization | 5.743836e-3 |
GO:0010982 | regulation of high-density lipoprotein particle clearance | 5.743836e-3 |
GO:0051343 | positive regulation of cyclic-nucleotide phosphodiesterase activity | 5.904895e-3 |
GO:0007100 | mitotic centrosome separation | 5.904895e-3 |
GO:0045716 | positive regulation of low-density lipoprotein particle receptor biosynthetic process | 5.904895e-3 |
GO:0051298 | centrosome duplication | 5.980223e-3 |
GO:0000387 | spliceosomal snRNP assembly | 5.980223e-3 |
GO:0006120 | mitochondrial electron transport, NADH to ubiquinone | 5.993591e-3 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 6.098529e-3 |
GO:0045739 | positive regulation of DNA repair | 6.138394e-3 |
GO:0042255 | ribosome assembly | 6.224104e-3 |
GO:0051793 | medium-chain fatty acid catabolic process | 6.235919e-3 |
GO:0014888 | striated muscle adaptation | 6.292762e-3 |
GO:0014034 | neural crest cell fate commitment | 6.444140e-3 |
GO:0045190 | isotype switching | 6.492386e-3 |
GO:0001946 | lymphangiogenesis | 6.511142e-3 |
GO:0071415 | cellular response to purine-containing compound | 6.583170e-3 |
GO:0051013 | microtubule severing | 6.583170e-3 |
GO:0006426 | glycyl-tRNA aminoacylation | 6.583170e-3 |
GO:0032859 | activation of Ral GTPase activity | 6.683660e-3 |
GO:0006399 | tRNA metabolic process | 6.767102e-3 |
GO:0009225 | nucleotide-sugar metabolic process | 6.881193e-3 |
GO:0070634 | transepithelial ammonium transport | 7.231294e-3 |
GO:0017121 | phospholipid scrambling | 7.348671e-3 |
GO:0008033 | tRNA processing | 7.435297e-3 |
GO:0007521 | muscle cell fate determination | 7.551245e-3 |
GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus | 7.819466e-3 |
GO:0006498 | N-terminal protein lipidation | 7.819466e-3 |
GO:0030852 | regulation of granulocyte differentiation | 7.866859e-3 |
GO:0015758 | glucose transport | 8.023293e-3 |
GO:0009219 | pyrimidine deoxyribonucleotide metabolic process | 8.028425e-3 |
GO:0010467 | gene expression | 8.036201e-3 |
GO:0006264 | mitochondrial DNA replication | 8.089810e-3 |
GO:0006281 | DNA repair | 8.107833e-3 |
GO:0060795 | cell fate commitment involved in formation of primary germ layers | 8.160594e-3 |
GO:0045908 | negative regulation of vasodilation | 8.540819e-3 |
GO:0042109 | lymphotoxin A biosynthetic process | 8.540819e-3 |
GO:0016576 | histone dephosphorylation | 8.727522e-3 |
GO:0014740 | negative regulation of muscle hyperplasia | 9.023625e-3 |
GO:0044264 | cellular polysaccharide metabolic process | 9.111015e-3 |
GO:0016072 | rRNA metabolic process | 9.119716e-3 |
GO:0072337 | modified amino acid transport | 9.161217e-3 |
GO:0006563 | L-serine metabolic process | 9.171265e-3 |
GO:0031639 | plasminogen activation | 9.197380e-3 |
GO:0002051 | osteoblast fate commitment | 9.214328e-3 |
GO:0070370 | cellular heat acclimation | 9.535721e-3 |
GO:0006844 | acyl carnitine transport | 9.535721e-3 |
GO:0006471 | protein ADP-ribosylation | 9.577055e-3 |
GO:0061013 | regulation of mRNA catabolic process | 9.685076e-3 |
GO:0006829 | zinc ion transport | 9.787781e-3 |
GO:0021520 | spinal cord motor neuron cell fate specification | 1.001879e-2 |
GO:0035048 | splicing factor protein import into nucleus | 1.024173e-2 |
GO:0070682 | proteasome regulatory particle assembly | 1.024173e-2 |
GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter | 1.028017e-2 |
GO:0070889 | platelet alpha granule organization | 1.030206e-2 |
GO:0048333 | mesodermal cell differentiation | 1.031867e-2 |
GO:0046323 | glucose import | 1.034949e-2 |
GO:0033133 | positive regulation of glucokinase activity | 1.034949e-2 |
GO:0071816 | tail-anchored membrane protein insertion into ER membrane | 1.041596e-2 |
GO:0042551 | neuron maturation | 1.057328e-2 |
GO:0003139 | secondary heart field specification | 1.114138e-2 |
GO:0031064 | negative regulation of histone deacetylation | 1.141317e-2 |
GO:0042775 | mitochondrial ATP synthesis coupled electron transport | 1.159595e-2 |
GO:0072500 | negative regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor | 1.160919e-2 |
GO:0006998 | nuclear envelope organization | 1.171795e-2 |
GO:0034645 | cellular macromolecule biosynthetic process | 1.203465e-2 |
GO:0002076 | osteoblast development | 1.231845e-2 |
GO:0001970 | positive regulation of activation of membrane attack complex | 1.241984e-2 |
GO:0032856 | activation of Ras GTPase activity | 1.245375e-2 |
GO:0042226 | interleukin-6 biosynthetic process | 1.248307e-2 |
GO:0046031 | ADP metabolic process | 1.248907e-2 |
GO:0032769 | negative regulation of monooxygenase activity | 1.250749e-2 |
GO:0045922 | negative regulation of fatty acid metabolic process | 1.252393e-2 |
GO:0032506 | cytokinetic process | 1.253533e-2 |
GO:0021569 | rhombomere 3 development | 1.253533e-2 |
GO:0090399 | replicative senescence | 1.268677e-2 |
GO:0006308 | DNA catabolic process | 1.281245e-2 |
GO:0006450 | regulation of translational fidelity | 1.301831e-2 |
GO:0033861 | negative regulation of NAD(P)H oxidase activity | 1.301831e-2 |
GO:0034154 | toll-like receptor 7 signaling pathway | 1.301831e-2 |
GO:0006478 | peptidyl-tyrosine sulfation | 1.301831e-2 |
GO:0016925 | protein sumoylation | 1.312725e-2 |
GO:0005978 | glycogen biosynthetic process | 1.312725e-2 |
GO:2000059 | negative regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process | 1.316736e-2 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 1.348756e-2 |
GO:0045019 | negative regulation of nitric oxide biosynthetic process | 1.356792e-2 |
GO:2000300 | regulation of synaptic vesicle exocytosis | 1.356792e-2 |
GO:0033599 | regulation of mammary gland epithelial cell proliferation | 1.365420e-2 |
GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA | 1.367238e-2 |
GO:0003094 | glomerular filtration | 1.367238e-2 |
GO:0048168 | regulation of neuronal synaptic plasticity | 1.414517e-2 |
GO:0009106 | lipoate metabolic process | 1.445128e-2 |
GO:0008588 | release of cytoplasmic sequestered NF-kappaB | 1.445743e-2 |
GO:0032855 | positive regulation of Rac GTPase activity | 1.458501e-2 |
GO:0006396 | RNA processing | 1.464985e-2 |
GO:0072655 | establishment of protein localization in mitochondrion | 1.465334e-2 |
GO:0030520 | estrogen receptor signaling pathway | 1.471348e-2 |
GO:0017148 | negative regulation of translation | 1.477203e-2 |
GO:0046967 | cytosol to ER transport | 1.485070e-2 |
GO:0060809 | mesodermal to mesenchymal transition involved in gastrulation | 1.485070e-2 |
GO:0045007 | depurination | 1.485070e-2 |
GO:0035425 | autocrine signaling | 1.485070e-2 |
GO:0002543 | activation of blood coagulation via clotting cascade | 1.486996e-2 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 1.491911e-2 |
GO:0022406 | membrane docking | 1.495940e-2 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 1.496055e-2 |
GO:0033484 | nitric oxide homeostasis | 1.496055e-2 |
GO:0048554 | positive regulation of metalloenzyme activity | 1.496355e-2 |
GO:0045836 | positive regulation of meiosis | 1.505375e-2 |
GO:0060999 | positive regulation of dendritic spine development | 1.514920e-2 |
GO:0015696 | ammonium transport | 1.514920e-2 |
GO:0070585 | protein localization in mitochondrion | 1.516724e-2 |
GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 1.518918e-2 |
GO:0032862 | activation of Rho GTPase activity | 1.531692e-2 |
GO:0015788 | UDP-N-acetylglucosamine transport | 1.623131e-2 |
GO:0021586 | pons maturation | 1.623131e-2 |
GO:0045714 | regulation of low-density lipoprotein particle receptor biosynthetic process | 1.630126e-2 |
GO:0003417 | growth plate cartilage development | 1.634835e-2 |
GO:0021546 | rhombomere development | 1.637105e-2 |
GO:0000271 | polysaccharide biosynthetic process | 1.664923e-2 |
GO:0046796 | viral genome transport in host cell | 1.672353e-2 |
GO:0045669 | positive regulation of osteoblast differentiation | 1.678945e-2 |
GO:0090304 | nucleic acid metabolic process | 1.694172e-2 |
GO:0003416 | endochondral bone growth | 1.703374e-2 |
GO:0006672 | ceramide metabolic process | 1.709682e-2 |
GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase | 1.713235e-2 |
GO:0002691 | regulation of cellular extravasation | 1.713235e-2 |
GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition | 1.750079e-2 |
GO:0006616 | SRP-dependent cotranslational protein targeting to membrane, translocation | 1.750079e-2 |
GO:0030509 | BMP signaling pathway | 1.760775e-2 |
GO:0071374 | cellular response to parathyroid hormone stimulus | 1.764047e-2 |
GO:0042396 | phosphagen biosynthetic process | 1.800004e-2 |
GO:0008633 | activation of pro-apoptotic gene products | 1.807030e-2 |
GO:0070934 | CRD-mediated mRNA stabilization | 1.849463e-2 |
GO:0051260 | protein homooligomerization | 1.851426e-2 |
GO:0022004 | midbrain-hindbrain boundary maturation during brain development | 1.867292e-2 |
GO:2000002 | negative regulation of DNA damage checkpoint | 1.867292e-2 |
GO:0021551 | central nervous system morphogenesis | 1.867292e-2 |
GO:0021588 | cerebellum formation | 1.867292e-2 |
GO:0019236 | response to pheromone | 1.867292e-2 |
GO:0055089 | fatty acid homeostasis | 1.873440e-2 |
GO:2000001 | regulation of DNA damage checkpoint | 1.873440e-2 |
GO:0003329 | pancreatic PP cell fate commitment | 1.873440e-2 |
GO:0003326 | pancreatic A cell fate commitment | 1.873440e-2 |
GO:0009450 | gamma-aminobutyric acid catabolic process | 1.873440e-2 |
GO:0019254 | carnitine metabolic process, CoA-linked | 1.891433e-2 |
GO:0030262 | apoptotic nuclear change | 1.901563e-2 |
GO:0007585 | respiratory gaseous exchange | 1.908008e-2 |
GO:0033145 | positive regulation of steroid hormone receptor signaling pathway | 1.959849e-2 |
GO:0014738 | regulation of muscle hyperplasia | 1.967748e-2 |
GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity | 1.967748e-2 |
GO:0046318 | negative regulation of glucosylceramide biosynthetic process | 1.978701e-2 |
GO:0032802 | low-density lipoprotein particle receptor catabolic process | 1.978701e-2 |
GO:0009234 | menaquinone biosynthetic process | 1.978701e-2 |
GO:0008052 | sensory organ boundary specification | 1.978701e-2 |
GO:0032464 | positive regulation of protein homooligomerization | 1.982186e-2 |
GO:0070537 | histone H2A K63-linked deubiquitination | 1.989954e-2 |
GO:0045818 | negative regulation of glycogen catabolic process | 1.989954e-2 |
GO:0048341 | paraxial mesoderm formation | 1.998842e-2 |
GO:0046519 | sphingoid metabolic process | 1.999370e-2 |
GO:0072144 | glomerular mesangial cell development | 2.044545e-2 |
GO:0072011 | glomerular endothelium development | 2.044545e-2 |
GO:0046086 | adenosine biosynthetic process | 2.044545e-2 |
GO:0035873 | lactate transmembrane transport | 2.044545e-2 |
GO:0002089 | lens morphogenesis in camera-type eye | 2.103318e-2 |
GO:0048845 | venous blood vessel morphogenesis | 2.133836e-2 |
GO:0051299 | centrosome separation | 2.146346e-2 |
GO:0048935 | peripheral nervous system neuron development | 2.147329e-2 |
GO:0045046 | protein import into peroxisome membrane | 2.159191e-2 |
GO:0008334 | histone mRNA metabolic process | 2.201271e-2 |
GO:0000079 | regulation of cyclin-dependent protein kinase activity | 2.289982e-2 |
GO:0000722 | telomere maintenance via recombination | 2.298783e-2 |
GO:0051313 | attachment of spindle microtubules to chromosome | 2.316732e-2 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.325207e-2 |
GO:0021571 | rhombomere 5 development | 2.336593e-2 |
GO:0071896 | protein localization to adherens junction | 2.370989e-2 |
GO:0070483 | detection of hypoxia | 2.370989e-2 |
GO:0007182 | common-partner SMAD protein phosphorylation | 2.370989e-2 |
GO:0061037 | negative regulation of cartilage development | 2.377765e-2 |
GO:0033600 | negative regulation of mammary gland epithelial cell proliferation | 2.377765e-2 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 2.403823e-2 |
GO:0046341 | CDP-diacylglycerol metabolic process | 2.403823e-2 |
GO:0018158 | protein oxidation | 2.403823e-2 |
GO:0001807 | regulation of type IV hypersensitivity | 2.403823e-2 |
GO:2000348 | regulation of CD40 signaling pathway | 2.421554e-2 |
GO:0022007 | convergent extension involved in neural plate elongation | 2.423467e-2 |
GO:0051256 | spindle midzone assembly involved in mitosis | 2.423467e-2 |
GO:0071217 | cellular response to external biotic stimulus | 2.454985e-2 |
GO:0031658 | negative regulation of cyclin-dependent protein kinase activity involved in G1/S | 2.454985e-2 |
GO:0006424 | glutamyl-tRNA aminoacylation | 2.454985e-2 |
GO:0007092 | activation of mitotic anaphase-promoting complex activity | 2.454985e-2 |
GO:0016142 | O-glycoside catabolic process | 2.454985e-2 |
GO:0061337 | cardiac conduction | 2.462527e-2 |
GO:0006119 | oxidative phosphorylation | 2.464575e-2 |
GO:0009313 | oligosaccharide catabolic process | 2.475019e-2 |
GO:0022617 | extracellular matrix disassembly | 2.475019e-2 |
GO:0006545 | glycine biosynthetic process | 2.475019e-2 |
GO:0045652 | regulation of megakaryocyte differentiation | 2.484193e-2 |
GO:0009059 | macromolecule biosynthetic process | 2.495935e-2 |
GO:0006359 | regulation of transcription from RNA polymerase III promoter | 2.500744e-2 |
GO:0006302 | double-strand break repair | 2.530931e-2 |
GO:0071071 | regulation of phospholipid biosynthetic process | 2.538392e-2 |
GO:0042351 | 'de novo' GDP-L-fucose biosynthetic process | 2.577016e-2 |
GO:0046498 | S-adenosylhomocysteine metabolic process | 2.599705e-2 |
GO:0005977 | glycogen metabolic process | 2.612265e-2 |
GO:0006386 | termination of RNA polymerase III transcription | 2.662611e-2 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 2.662611e-2 |
GO:0019321 | pentose metabolic process | 2.686388e-2 |
GO:0046755 | non-lytic virus budding | 2.726064e-2 |
GO:0010971 | positive regulation of G2/M transition of mitotic cell cycle | 2.726064e-2 |
GO:0009785 | blue light signaling pathway | 2.726064e-2 |
GO:0051898 | negative regulation of protein kinase B signaling cascade | 2.752135e-2 |
GO:0060213 | positive regulation of nuclear-transcribed mRNA poly(A) tail shortening | 2.815098e-2 |
GO:0032508 | DNA duplex unwinding | 2.844208e-2 |
GO:0032201 | telomere maintenance via semi-conservative replication | 2.844208e-2 |
GO:2000286 | receptor internalization involved in canonical Wnt receptor signaling pathway | 2.846805e-2 |
GO:0034214 | protein hexamerization | 2.846805e-2 |
GO:0008355 | olfactory learning | 2.865905e-2 |
GREAT analysis results for mouseGenomic Enrichment of Annotations Tool (GREAT, Nat Biotechnol. 2010 May;28(5):495-501) is used to identify, both in human and in mouse, the gene ontology terms of biological processes enriched given the predicted TFBSs, and evaluated the overlap in the top-500 gene ontology terms between human and mouse. For each novel motif, the P value for the overlap was then evaluated by calculating its relative rank with respect to this background distribution.<br>Analyst: Michiel de Hoon <br><br>link to source dataset <br>data
GO ID | GO Term | p-value |
---|---|---|
GO:0044260 | cellular macromolecule metabolic process | 1.983640e-9 |
GO:2000623 | negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay | 2.022085e-9 |
GO:0042048 | olfactory behavior | 1.644578e-8 |
GO:0090304 | nucleic acid metabolic process | 8.840370e-8 |
GO:0015986 | ATP synthesis coupled proton transport | 1.514469e-7 |
GO:0070858 | negative regulation of bile acid biosynthetic process | 6.869425e-7 |
GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 1.672406e-6 |
GO:0006281 | DNA repair | 2.839882e-6 |
GO:0070857 | regulation of bile acid biosynthetic process | 3.296818e-6 |
GO:0034645 | cellular macromolecule biosynthetic process | 3.646313e-6 |
GO:0010467 | gene expression | 3.920628e-6 |
GO:0009059 | macromolecule biosynthetic process | 4.319174e-6 |
GO:0006139 | nucleobase-containing compound metabolic process | 4.377025e-6 |
GO:0018193 | peptidyl-amino acid modification | 1.102637e-5 |
GO:0006259 | DNA metabolic process | 1.263815e-5 |
GO:0071034 | CUT catabolic process | 1.303880e-5 |
GO:0046031 | ADP metabolic process | 1.334840e-5 |
GO:0006099 | tricarboxylic acid cycle | 1.737975e-5 |
GO:0006807 | nitrogen compound metabolic process | 1.771454e-5 |
GO:0048704 | embryonic skeletal system morphogenesis | 2.033907e-5 |
GO:0002098 | tRNA wobble uridine modification | 2.703658e-5 |
GO:0002536 | respiratory burst involved in inflammatory response | 2.912920e-5 |
GO:0002924 | negative regulation of humoral immune response mediated by circulating immunoglobulin | 3.326609e-5 |
GO:0090083 | regulation of inclusion body assembly | 3.512649e-5 |
GO:0007183 | SMAD protein complex assembly | 3.592654e-5 |
GO:0035137 | hindlimb morphogenesis | 3.747472e-5 |
GO:0044237 | cellular metabolic process | 3.877994e-5 |
GO:0006102 | isocitrate metabolic process | 4.116843e-5 |
GO:2001052 | positive regulation of G1/S transition checkpoint | 4.184638e-5 |
GO:0072574 | hepatocyte proliferation | 4.184638e-5 |
GO:0002194 | hepatocyte cell migration | 4.184638e-5 |
GO:0043966 | histone H3 acetylation | 4.480481e-5 |
GO:0071108 | protein K48-linked deubiquitination | 4.734577e-5 |
GO:0034641 | cellular nitrogen compound metabolic process | 4.737961e-5 |
GO:0046356 | acetyl-CoA catabolic process | 5.027326e-5 |
GO:0090084 | negative regulation of inclusion body assembly | 5.486047e-5 |
GO:0034227 | tRNA thio-modification | 5.486047e-5 |
GO:0009992 | cellular water homeostasis | 5.878173e-5 |
GO:0043170 | macromolecule metabolic process | 5.903280e-5 |
GO:0042267 | natural killer cell mediated cytotoxicity | 6.210783e-5 |
GO:0007000 | nucleolus organization | 7.160710e-5 |
GO:0060674 | placenta blood vessel development | 7.863733e-5 |
GO:0006260 | DNA replication | 8.274537e-5 |
GO:0050860 | negative regulation of T cell receptor signaling pathway | 8.915572e-5 |
GO:0009452 | RNA capping | 9.077546e-5 |
GO:0018105 | peptidyl-serine phosphorylation | 1.088518e-4 |
GO:0032077 | positive regulation of deoxyribonuclease activity | 1.164684e-4 |
GO:0070537 | histone H2A K63-linked deubiquitination | 1.179134e-4 |
GO:0009060 | aerobic respiration | 1.307030e-4 |
GO:0061003 | positive regulation of dendritic spine morphogenesis | 1.324939e-4 |
GO:0035136 | forelimb morphogenesis | 1.345030e-4 |
GO:0007635 | chemosensory behavior | 1.375450e-4 |
GO:0006308 | DNA catabolic process | 1.413355e-4 |
GO:0009109 | coenzyme catabolic process | 1.463993e-4 |
GO:0016197 | endosome transport | 1.798487e-4 |
GO:0016070 | RNA metabolic process | 1.904031e-4 |
GO:0007004 | telomere maintenance via telomerase | 2.115461e-4 |
GO:0050856 | regulation of T cell receptor signaling pathway | 2.223168e-4 |
GO:0060298 | positive regulation of sarcomere organization | 2.314709e-4 |
GO:0048935 | peripheral nervous system neuron development | 2.545339e-4 |
GO:0006756 | AMP phosphorylation | 2.566099e-4 |
GO:0001895 | retina homeostasis | 2.972456e-4 |
GO:0006603 | phosphocreatine metabolic process | 3.152186e-4 |
GO:0060708 | spongiotrophoblast differentiation | 3.152186e-4 |
GO:0072355 | histone H3-T3 phosphorylation | 3.395325e-4 |
GO:0006972 | hyperosmotic response | 3.644842e-4 |
GO:0018364 | peptidyl-glutamine methylation | 3.830981e-4 |
GO:0030070 | insulin processing | 3.888761e-4 |
GO:0071474 | cellular hyperosmotic response | 3.888761e-4 |
GO:0006013 | mannose metabolic process | 4.043265e-4 |
GO:0051187 | cofactor catabolic process | 4.250412e-4 |
GO:0009179 | purine ribonucleoside diphosphate metabolic process | 4.288590e-4 |
GO:0048025 | negative regulation of nuclear mRNA splicing, via spliceosome | 4.641532e-4 |
GO:0046619 | optic placode formation involved in camera-type eye formation | 4.974149e-4 |
GO:0015992 | proton transport | 5.018431e-4 |
GO:0035511 | oxidative DNA demethylation | 5.083884e-4 |
GO:0006657 | CDP-choline pathway | 5.346325e-4 |
GO:0071526 | semaphorin-plexin signaling pathway | 5.447842e-4 |
GO:0046940 | nucleoside monophosphate phosphorylation | 5.515388e-4 |
GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process | 5.670907e-4 |
GO:0046967 | cytosol to ER transport | 5.874566e-4 |
GO:0019060 | intracellular transport of viral proteins in host cell | 5.874566e-4 |
GO:0033979 | box H/ACA snoRNA metabolic process | 5.874566e-4 |
GO:0006818 | hydrogen transport | 5.979834e-4 |
GO:0060318 | definitive erythrocyte differentiation | 6.137410e-4 |
GO:0035552 | oxidative single-stranded DNA demethylation | 6.155487e-4 |
GO:0044262 | cellular carbohydrate metabolic process | 6.233120e-4 |
GO:0030262 | apoptotic nuclear change | 6.292999e-4 |
GO:0007094 | mitotic cell cycle spindle assembly checkpoint | 6.374991e-4 |
GO:0045862 | positive regulation of proteolysis | 6.438307e-4 |
GO:0001909 | leukocyte mediated cytotoxicity | 6.481639e-4 |
GO:0021520 | spinal cord motor neuron cell fate specification | 6.535125e-4 |
GO:0044249 | cellular biosynthetic process | 6.803056e-4 |
GO:0006302 | double-strand break repair | 6.852942e-4 |
GO:0071174 | mitotic cell cycle spindle checkpoint | 7.408608e-4 |
GO:2000378 | negative regulation of reactive oxygen species metabolic process | 7.595291e-4 |
GO:0048706 | embryonic skeletal system development | 7.656220e-4 |
GO:0060179 | male mating behavior | 7.700200e-4 |
GO:0000492 | box C/D snoRNP assembly | 7.700200e-4 |
GO:0061013 | regulation of mRNA catabolic process | 7.801615e-4 |
GO:0045739 | positive regulation of DNA repair | 8.172678e-4 |
GO:0032774 | RNA biosynthetic process | 8.715320e-4 |
GO:0002483 | antigen processing and presentation of endogenous peptide antigen | 9.109768e-4 |
GO:0019673 | GDP-mannose metabolic process | 9.180111e-4 |
GO:0001743 | optic placode formation | 9.180111e-4 |
GO:0051881 | regulation of mitochondrial membrane potential | 9.270254e-4 |
GO:0035674 | tricarboxylic acid transmembrane transport | 9.411898e-4 |
GO:0008355 | olfactory learning | 9.411898e-4 |
GO:0033119 | negative regulation of RNA splicing | 9.620711e-4 |
GO:0055005 | ventricular cardiac myofibril development | 1.007283e-3 |
GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway | 1.021093e-3 |
GO:0035269 | protein O-linked mannosylation | 1.047110e-3 |
GO:0006309 | DNA fragmentation involved in apoptotic nuclear change | 1.061237e-3 |
GO:0002030 | inhibitory G-protein coupled receptor phosphorylation | 1.072757e-3 |
GO:0090138 | regulation of actin cytoskeleton organization by cell-cell adhesion | 1.081061e-3 |
GO:0042443 | phenylethylamine metabolic process | 1.081061e-3 |
GO:0070535 | histone H2A K63-linked ubiquitination | 1.081061e-3 |
GO:0006351 | transcription, DNA-dependent | 1.109966e-3 |
GO:0071874 | cellular response to norepinephrine stimulus | 1.135422e-3 |
GO:0002051 | osteoblast fate commitment | 1.167986e-3 |
GO:0048050 | post-embryonic eye morphogenesis | 1.178929e-3 |
GO:0006044 | N-acetylglucosamine metabolic process | 1.256609e-3 |
GO:0015012 | heparan sulfate proteoglycan biosynthetic process | 1.299413e-3 |
GO:0043631 | RNA polyadenylation | 1.319676e-3 |
GO:0071870 | cellular response to catecholamine stimulus | 1.412421e-3 |
GO:0035621 | ER to Golgi ceramide transport | 1.421856e-3 |
GO:2001022 | positive regulation of response to DNA damage stimulus | 1.453157e-3 |
GO:0035767 | endothelial cell chemotaxis | 1.481258e-3 |
GO:0006307 | DNA dealkylation involved in DNA repair | 1.481955e-3 |
GO:0051252 | regulation of RNA metabolic process | 1.564911e-3 |
GO:0046033 | AMP metabolic process | 1.586747e-3 |
GO:0060433 | bronchus development | 1.586747e-3 |
GO:0006527 | arginine catabolic process | 1.648916e-3 |
GO:0006172 | ADP biosynthetic process | 1.648916e-3 |
GO:0043407 | negative regulation of MAP kinase activity | 1.653059e-3 |
GO:0006921 | cellular component disassembly involved in apoptosis | 1.668706e-3 |
GO:0030201 | heparan sulfate proteoglycan metabolic process | 1.684529e-3 |
GO:0009058 | biosynthetic process | 1.767587e-3 |
GO:0070935 | 3'-UTR-mediated mRNA stabilization | 1.813284e-3 |
GO:0000045 | autophagic vacuole assembly | 1.825234e-3 |
GO:0030953 | astral microtubule organization | 1.837174e-3 |
GO:0006023 | aminoglycan biosynthetic process | 2.005145e-3 |
GO:0050917 | sensory perception of umami taste | 2.012652e-3 |
GO:0018192 | enzyme active site formation via L-cysteine persulfide | 2.050510e-3 |
GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity | 2.050510e-3 |
GO:0022417 | protein maturation by protein folding | 2.050510e-3 |
GO:2000688 | positive regulation of rubidium ion transmembrane transporter activity | 2.083359e-3 |
GO:2000682 | positive regulation of rubidium ion transport | 2.083359e-3 |
GO:0010430 | fatty acid omega-oxidation | 2.083359e-3 |
GO:0035826 | rubidium ion transport | 2.083359e-3 |
GO:0070989 | oxidative demethylation | 2.111423e-3 |
GO:0002679 | respiratory burst involved in defense response | 2.128439e-3 |
GO:0006378 | mRNA polyadenylation | 2.137754e-3 |
GO:2000112 | regulation of cellular macromolecule biosynthetic process | 2.233110e-3 |
GO:0035115 | embryonic forelimb morphogenesis | 2.315395e-3 |
GO:0016573 | histone acetylation | 2.396696e-3 |
GO:0048268 | clathrin coat assembly | 2.512421e-3 |
GO:0032456 | endocytic recycling | 2.512421e-3 |
GO:0060712 | spongiotrophoblast layer development | 2.569290e-3 |
GO:0045841 | negative regulation of mitotic metaphase/anaphase transition | 2.569290e-3 |
GO:0046549 | retinal cone cell development | 2.569290e-3 |
GO:0006901 | vesicle coating | 2.741955e-3 |
GO:0000271 | polysaccharide biosynthetic process | 2.813027e-3 |
GO:0008380 | RNA splicing | 2.828437e-3 |
GO:0045333 | cellular respiration | 2.926180e-3 |
GO:0006304 | DNA modification | 2.941172e-3 |
GO:0010556 | regulation of macromolecule biosynthetic process | 2.971629e-3 |
GO:0045006 | DNA deamination | 2.972943e-3 |
GO:0006091 | generation of precursor metabolites and energy | 3.081356e-3 |
GO:0045740 | positive regulation of DNA replication | 3.086829e-3 |
GO:0002921 | negative regulation of humoral immune response | 3.114192e-3 |
GO:0006457 | protein folding | 3.136367e-3 |
GO:0018209 | peptidyl-serine modification | 3.173838e-3 |
GO:0090305 | nucleic acid phosphodiester bond hydrolysis | 3.202681e-3 |
GO:0006401 | RNA catabolic process | 3.336585e-3 |
GO:0016074 | snoRNA metabolic process | 3.410487e-3 |
GO:0071173 | spindle assembly checkpoint | 3.411072e-3 |
GO:0045541 | negative regulation of cholesterol biosynthetic process | 3.470536e-3 |
GO:2000781 | positive regulation of double-strand break repair | 3.513407e-3 |
GO:0021586 | pons maturation | 3.513407e-3 |
GO:0048024 | regulation of nuclear mRNA splicing, via spliceosome | 3.529146e-3 |
GO:0003198 | epithelial to mesenchymal transition involved in endocardial cushion formation | 3.543908e-3 |
GO:0002523 | leukocyte migration involved in inflammatory response | 3.543908e-3 |
GO:0006310 | DNA recombination | 3.645544e-3 |
GO:0006268 | DNA unwinding involved in replication | 3.800217e-3 |
GO:0010595 | positive regulation of endothelial cell migration | 3.821893e-3 |
GO:0060377 | negative regulation of mast cell differentiation | 3.833679e-3 |
GO:0006043 | glucosamine catabolic process | 3.833679e-3 |
GO:0034661 | ncRNA catabolic process | 3.836202e-3 |
GO:0006878 | cellular copper ion homeostasis | 3.838394e-3 |
GO:0001832 | blastocyst growth | 3.846258e-3 |
GO:0010310 | regulation of hydrogen peroxide metabolic process | 3.951948e-3 |
GO:0005996 | monosaccharide metabolic process | 3.962468e-3 |
GO:0072143 | mesangial cell development | 3.998192e-3 |
GO:0045943 | positive regulation of transcription from RNA polymerase I promoter | 3.998192e-3 |
GO:0010468 | regulation of gene expression | 4.023612e-3 |
GO:0060272 | embryonic skeletal joint morphogenesis | 4.070672e-3 |
GO:0021658 | rhombomere 3 morphogenesis | 4.097225e-3 |
GO:0060434 | bronchus morphogenesis | 4.097225e-3 |
GO:0048280 | vesicle fusion with Golgi apparatus | 4.097225e-3 |
GO:0032968 | positive regulation of transcription elongation from RNA polymerase II promoter | 4.097225e-3 |
GO:0009202 | deoxyribonucleoside triphosphate biosynthetic process | 4.097225e-3 |
GO:0010833 | telomere maintenance via telomere lengthening | 4.097225e-3 |
GO:0010890 | positive regulation of sequestering of triglyceride | 4.097225e-3 |
GO:0046939 | nucleotide phosphorylation | 4.138084e-3 |
GO:0050868 | negative regulation of T cell activation | 4.191203e-3 |
GO:0051568 | histone H3-K4 methylation | 4.206685e-3 |
GO:0010894 | negative regulation of steroid biosynthetic process | 4.206685e-3 |
GO:0032434 | regulation of proteasomal ubiquitin-dependent protein catabolic process | 4.264861e-3 |
GO:0018393 | internal peptidyl-lysine acetylation | 4.324047e-3 |
GO:0048701 | embryonic cranial skeleton morphogenesis | 4.398099e-3 |
GO:0031122 | cytoplasmic microtubule organization | 4.440578e-3 |
GO:0045190 | isotype switching | 4.455487e-3 |
GO:0072133 | metanephric mesenchyme morphogenesis | 4.459313e-3 |
GO:0000083 | regulation of transcription involved in G1/S phase of mitotic cell cycle | 4.524522e-3 |
GO:0031558 | induction of apoptosis in response to chemical stimulus | 4.682126e-3 |
GO:0016236 | macroautophagy | 4.733963e-3 |
GO:0018394 | peptidyl-lysine acetylation | 4.784160e-3 |
GO:0009185 | ribonucleoside diphosphate metabolic process | 4.794058e-3 |
GO:0035116 | embryonic hindlimb morphogenesis | 4.846218e-3 |
GO:0018107 | peptidyl-threonine phosphorylation | 4.915303e-3 |
GO:0002063 | chondrocyte development | 4.969940e-3 |
GO:0015746 | citrate transport | 5.027184e-3 |
GO:0008216 | spermidine metabolic process | 5.027184e-3 |
GO:0006475 | internal protein amino acid acetylation | 5.107004e-3 |
GO:0032287 | peripheral nervous system myelin maintenance | 5.157472e-3 |
GO:0030166 | proteoglycan biosynthetic process | 5.187133e-3 |
GO:0046907 | intracellular transport | 5.209326e-3 |
GO:0072498 | embryonic skeletal joint development | 5.247580e-3 |
GO:0060255 | regulation of macromolecule metabolic process | 5.311820e-3 |
GO:0048665 | neuron fate specification | 5.326336e-3 |
GO:0018205 | peptidyl-lysine modification | 5.378681e-3 |
GO:0043951 | negative regulation of cAMP-mediated signaling | 5.409070e-3 |
GO:0070318 | positive regulation of G0 to G1 transition | 5.409070e-3 |
GO:0060064 | Spemann organizer formation at the anterior end of the primitive streak | 5.417732e-3 |
GO:0046596 | regulation of virion penetration into host cell | 5.417732e-3 |
GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification | 5.417732e-3 |
GO:0045992 | negative regulation of embryonic development | 5.417732e-3 |
GO:0042840 | D-glucuronate catabolic process | 5.417732e-3 |
GO:0016052 | carbohydrate catabolic process | 5.444487e-3 |
GO:0035966 | response to topologically incorrect protein | 5.657000e-3 |
GO:0007090 | regulation of S phase of mitotic cell cycle | 5.661827e-3 |
GO:0006355 | regulation of transcription, DNA-dependent | 5.675149e-3 |
GO:0048814 | regulation of dendrite morphogenesis | 5.693858e-3 |
GO:0022027 | interkinetic nuclear migration | 5.694526e-3 |
GO:0030104 | water homeostasis | 5.699657e-3 |
GO:0045839 | negative regulation of mitosis | 5.699657e-3 |
GO:0002904 | positive regulation of B cell apoptosis | 5.715325e-3 |
GO:0006275 | regulation of DNA replication | 5.727669e-3 |
GO:0009142 | nucleoside triphosphate biosynthetic process | 5.731151e-3 |
GO:0060214 | endocardium formation | 5.854596e-3 |
GO:0045581 | negative regulation of T cell differentiation | 5.923454e-3 |
GO:0060999 | positive regulation of dendritic spine development | 6.063913e-3 |
GO:0001967 | suckling behavior | 6.093644e-3 |
GO:0003160 | endocardium morphogenesis | 6.170887e-3 |
GO:0044275 | cellular carbohydrate catabolic process | 6.188873e-3 |
GO:0031577 | spindle checkpoint | 6.293703e-3 |
GO:0055070 | copper ion homeostasis | 6.355728e-3 |
GO:0006473 | protein acetylation | 6.379391e-3 |
GO:0006782 | protoporphyrinogen IX biosynthetic process | 6.446239e-3 |
GO:0070166 | enamel mineralization | 6.493148e-3 |
GO:0008633 | activation of pro-apoptotic gene products | 6.574249e-3 |
GO:0032508 | DNA duplex unwinding | 6.609845e-3 |
GO:0016578 | histone deubiquitination | 6.609845e-3 |
GO:0046039 | GTP metabolic process | 6.660598e-3 |
GO:0071044 | histone mRNA catabolic process | 6.916010e-3 |
GO:0070407 | oxidation-dependent protein catabolic process | 6.922996e-3 |
GO:0006348 | chromatin silencing at telomere | 6.922996e-3 |
GO:0070370 | cellular heat acclimation | 6.922996e-3 |
GO:0033327 | Leydig cell differentiation | 7.135470e-3 |
GO:0006024 | glycosaminoglycan biosynthetic process | 7.180534e-3 |
GO:0050775 | positive regulation of dendrite morphogenesis | 7.302140e-3 |
GO:0006184 | GTP catabolic process | 7.397234e-3 |
GO:0007422 | peripheral nervous system development | 7.409315e-3 |
GO:0072593 | reactive oxygen species metabolic process | 7.410507e-3 |
GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation | 7.459138e-3 |
GO:0060317 | cardiac epithelial to mesenchymal transition | 7.588231e-3 |
GO:0060297 | regulation of sarcomere organization | 7.588231e-3 |
GO:0006396 | RNA processing | 7.617171e-3 |
GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity | 7.720724e-3 |
GO:0046882 | negative regulation of follicle-stimulating hormone secretion | 7.720724e-3 |
GO:0046015 | regulation of transcription by glucose | 7.733200e-3 |
GO:0032392 | DNA geometric change | 7.816784e-3 |
GO:0015790 | UDP-xylose transport | 7.832869e-3 |
GO:0048697 | positive regulation of collateral sprouting in absence of injury | 7.832869e-3 |
GO:0015788 | UDP-N-acetylglucosamine transport | 7.832869e-3 |
GO:0012502 | induction of programmed cell death | 7.898563e-3 |
GO:0006974 | response to DNA damage stimulus | 7.902960e-3 |
GO:0071901 | negative regulation of protein serine/threonine kinase activity | 7.982363e-3 |
GO:0045931 | positive regulation of mitotic cell cycle | 8.089194e-3 |
GO:0071422 | succinate transmembrane transport | 8.107510e-3 |
GO:0001830 | trophectodermal cell fate commitment | 8.107510e-3 |
GO:0016139 | glycoside catabolic process | 8.107510e-3 |
GO:0042474 | middle ear morphogenesis | 8.118173e-3 |
GO:0044238 | primary metabolic process | 8.298421e-3 |
GO:0006282 | regulation of DNA repair | 8.369106e-3 |
GO:0009154 | purine ribonucleotide catabolic process | 8.411897e-3 |
GO:0006917 | induction of apoptosis | 8.469964e-3 |
GO:0042069 | regulation of catecholamine metabolic process | 8.480500e-3 |
GO:0016572 | histone phosphorylation | 8.651936e-3 |
GO:0051054 | positive regulation of DNA metabolic process | 8.699273e-3 |
GO:0010741 | negative regulation of intracellular protein kinase cascade | 8.914249e-3 |
GO:0080111 | DNA demethylation | 9.067424e-3 |
GO:0072098 | anterior/posterior pattern specification involved in kidney development | 9.100680e-3 |
GO:0048389 | intermediate mesoderm development | 9.100680e-3 |
GO:0019348 | dolichol metabolic process | 9.100680e-3 |
GO:0043409 | negative regulation of MAPKKK cascade | 9.164258e-3 |
GO:0050684 | regulation of mRNA processing | 9.260380e-3 |
GO:0003188 | heart valve formation | 9.334463e-3 |
GO:0019730 | antimicrobial humoral response | 9.361330e-3 |
GO:0009150 | purine ribonucleotide metabolic process | 9.696187e-3 |
GO:0030326 | embryonic limb morphogenesis | 9.826686e-3 |
GO:0043508 | negative regulation of JUN kinase activity | 9.936736e-3 |
GO:0035510 | DNA dealkylation | 9.936736e-3 |
GO:0071460 | cellular response to cell-matrix adhesion | 1.002629e-2 |
GO:0002476 | antigen processing and presentation of endogenous peptide antigen via MHC class Ib | 1.002629e-2 |
GO:0035553 | oxidative single-stranded RNA demethylation | 1.002629e-2 |
GO:0042364 | water-soluble vitamin biosynthetic process | 1.003704e-2 |
GO:0042147 | retrograde transport, endosome to Golgi | 1.011498e-2 |
GO:0009141 | nucleoside triphosphate metabolic process | 1.040348e-2 |
GO:0060319 | primitive erythrocyte differentiation | 1.043666e-2 |
GO:0019852 | L-ascorbic acid metabolic process | 1.043902e-2 |
GO:0030818 | negative regulation of cAMP biosynthetic process | 1.053804e-2 |
GO:0070316 | regulation of G0 to G1 transition | 1.064156e-2 |
GO:0044154 | histone H3-K14 acetylation | 1.064156e-2 |
GO:0000956 | nuclear-transcribed mRNA catabolic process | 1.066814e-2 |
GO:0060061 | Spemann organizer formation | 1.078645e-2 |
GO:0001709 | cell fate determination | 1.093922e-2 |
GO:0061001 | regulation of dendritic spine morphogenesis | 1.106280e-2 |
GO:0009143 | nucleoside triphosphate catabolic process | 1.112097e-2 |
GO:0042733 | embryonic digit morphogenesis | 1.135171e-2 |
GO:0019432 | triglyceride biosynthetic process | 1.137781e-2 |
GO:0051403 | stress-activated MAPK cascade | 1.138514e-2 |
GO:0018210 | peptidyl-threonine modification | 1.149687e-2 |
GO:0009261 | ribonucleotide catabolic process | 1.153758e-2 |
GO:0072190 | ureter urothelium development | 1.159898e-2 |
GO:0019853 | L-ascorbic acid biosynthetic process | 1.168994e-2 |
GO:0007033 | vacuole organization | 1.181228e-2 |
GO:0018108 | peptidyl-tyrosine phosphorylation | 1.181228e-2 |
GO:0016050 | vesicle organization | 1.181228e-2 |
GO:0060219 | camera-type eye photoreceptor cell differentiation | 1.213023e-2 |
GO:0090086 | negative regulation of protein deubiquitination | 1.221643e-2 |
GO:0033603 | positive regulation of dopamine secretion | 1.221643e-2 |
GO:0046709 | IDP catabolic process | 1.235149e-2 |
GO:0046032 | ADP catabolic process | 1.235149e-2 |
GO:0070571 | negative regulation of neuron projection regeneration | 1.245991e-2 |
GO:0022038 | corpus callosum development | 1.246827e-2 |
GO:0071845 | cellular component disassembly at cellular level | 1.247577e-2 |
GO:0042554 | superoxide anion generation | 1.284233e-2 |
GO:0009146 | purine nucleoside triphosphate catabolic process | 1.326525e-2 |
GO:0070164 | negative regulation of adiponectin secretion | 1.339718e-2 |
GO:0045769 | negative regulation of asymmetric cell division | 1.339718e-2 |
GO:0090241 | negative regulation of histone H4 acetylation | 1.339718e-2 |
GO:0035505 | positive regulation of myosin light chain kinase activity | 1.339718e-2 |
GO:0014908 | myotube differentiation involved in skeletal muscle regeneration | 1.339718e-2 |
GO:0034401 | regulation of transcription by chromatin organization | 1.339718e-2 |
GO:0007518 | myoblast cell fate determination | 1.339718e-2 |
GO:0009145 | purine nucleoside triphosphate biosynthetic process | 1.361456e-2 |
GO:0043983 | histone H4-K12 acetylation | 1.362596e-2 |
GO:0061136 | regulation of proteasomal protein catabolic process | 1.365787e-2 |
GO:0009207 | purine ribonucleoside triphosphate catabolic process | 1.369664e-2 |
GO:0051705 | behavioral interaction between organisms | 1.375470e-2 |
GO:0006986 | response to unfolded protein | 1.375470e-2 |
GO:0006801 | superoxide metabolic process | 1.387098e-2 |
GO:0061312 | BMP signaling pathway involved in heart development | 1.400687e-2 |
GO:0002268 | follicular dendritic cell differentiation | 1.400687e-2 |
GO:0019430 | removal of superoxide radicals | 1.401102e-2 |
GO:0045662 | negative regulation of myoblast differentiation | 1.416532e-2 |
GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator | 1.423820e-2 |
GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation | 1.423820e-2 |
GO:0071539 | protein localization to centrosome | 1.429817e-2 |
GO:0001834 | trophectodermal cell proliferation | 1.429817e-2 |
GO:0006235 | dTTP biosynthetic process | 1.429817e-2 |
GO:0031326 | regulation of cellular biosynthetic process | 1.447725e-2 |
GO:0002312 | B cell activation involved in immune response | 1.448193e-2 |
GO:0022411 | cellular component disassembly | 1.453701e-2 |
GO:0006195 | purine nucleotide catabolic process | 1.460878e-2 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 1.464092e-2 |
GO:0006040 | amino sugar metabolic process | 1.467050e-2 |
GO:0009231 | riboflavin biosynthetic process | 1.469025e-2 |
GO:0046463 | acylglycerol biosynthetic process | 1.472978e-2 |
GO:0009889 | regulation of biosynthetic process | 1.502587e-2 |
GO:0005975 | carbohydrate metabolic process | 1.528073e-2 |
GO:0006734 | NADH metabolic process | 1.564340e-2 |
GO:0072132 | mesenchyme morphogenesis | 1.568118e-2 |
GO:0035284 | brain segmentation | 1.568269e-2 |
GO:0060684 | epithelial-mesenchymal cell signaling | 1.601798e-2 |
GO:0060414 | aorta smooth muscle tissue morphogenesis | 1.617224e-2 |
GO:0006397 | mRNA processing | 1.627297e-2 |
GO:0032277 | negative regulation of gonadotropin secretion | 1.630891e-2 |
GO:0034214 | protein hexamerization | 1.630891e-2 |
GO:0007403 | glial cell fate determination | 1.630891e-2 |
GO:0009144 | purine nucleoside triphosphate metabolic process | 1.655725e-2 |
GO:0010821 | regulation of mitochondrion organization | 1.657700e-2 |
GO:0030240 | skeletal muscle thin filament assembly | 1.699362e-2 |
GO:0009259 | ribonucleotide metabolic process | 1.729786e-2 |
GO:0042130 | negative regulation of T cell proliferation | 1.735901e-2 |
GO:0009205 | purine ribonucleoside triphosphate metabolic process | 1.742703e-2 |
GO:0042245 | RNA repair | 1.745855e-2 |
GO:0042727 | flavin-containing compound biosynthetic process | 1.745855e-2 |
GO:0021660 | rhombomere 3 formation | 1.745855e-2 |
GO:0021666 | rhombomere 5 formation | 1.745855e-2 |
GO:0002352 | B cell negative selection | 1.745855e-2 |
GO:0072144 | glomerular mesangial cell development | 1.749212e-2 |
GO:0048312 | intracellular distribution of mitochondria | 1.749212e-2 |
GO:0045014 | negative regulation of transcription by glucose | 1.749212e-2 |
GO:0043217 | myelin maintenance | 1.756650e-2 |
GO:0051148 | negative regulation of muscle cell differentiation | 1.758841e-2 |
GO:0051220 | cytoplasmic sequestering of protein | 1.772500e-2 |
GO:0019048 | virus-host interaction | 1.805440e-2 |
GO:0045980 | negative regulation of nucleotide metabolic process | 1.816660e-2 |
GO:0009199 | ribonucleoside triphosphate metabolic process | 1.830164e-2 |
GO:0050916 | sensory perception of sweet taste | 1.838072e-2 |
GO:0045299 | otolith mineralization | 1.838072e-2 |
GO:0000917 | barrier septum formation | 1.838072e-2 |
GO:0015781 | pyrimidine nucleotide-sugar transport | 1.838072e-2 |
GO:0006914 | autophagy | 1.840076e-2 |
GO:0010512 | negative regulation of phosphatidylinositol biosynthetic process | 1.857033e-2 |
GO:0006289 | nucleotide-excision repair | 1.868687e-2 |
GO:0031123 | RNA 3'-end processing | 1.879830e-2 |
GO:0046855 | inositol phosphate dephosphorylation | 1.884204e-2 |
GO:0016051 | carbohydrate biosynthetic process | 1.888160e-2 |
GO:0022028 | tangential migration from the subventricular zone to the olfactory bulb | 1.894299e-2 |
GO:0006767 | water-soluble vitamin metabolic process | 1.899622e-2 |
GO:0006402 | mRNA catabolic process | 1.917646e-2 |
GO:0031323 | regulation of cellular metabolic process | 1.923415e-2 |
GO:0016071 | mRNA metabolic process | 1.946068e-2 |
GO:0051171 | regulation of nitrogen compound metabolic process | 1.946766e-2 |
GO:0001710 | mesodermal cell fate commitment | 1.959795e-2 |
GO:0055015 | ventricular cardiac muscle cell development | 1.997850e-2 |
GO:0003009 | skeletal muscle contraction | 1.997850e-2 |
GO:0033692 | cellular polysaccharide biosynthetic process | 2.004960e-2 |
GO:0070925 | organelle assembly | 2.008082e-2 |
GO:0048663 | neuron fate commitment | 2.013360e-2 |
GO:0048488 | synaptic vesicle endocytosis | 2.029333e-2 |
GO:0046501 | protoporphyrinogen IX metabolic process | 2.053057e-2 |
GO:0071733 | transcriptional activation by promoter-enhancer looping | 2.053057e-2 |
GO:2000774 | positive regulation of cellular senescence | 2.060102e-2 |
GO:0090402 | oncogene-induced senescence | 2.060102e-2 |
GO:0035986 | senescence-associated heterochromatin focus formation | 2.060102e-2 |
GO:0060421 | positive regulation of heart growth | 2.060102e-2 |
GO:0060440 | trachea formation | 2.060102e-2 |
GO:0010544 | negative regulation of platelet activation | 2.060991e-2 |
GO:0045730 | respiratory burst | 2.069503e-2 |
GO:0050925 | negative regulation of negative chemotaxis | 2.102865e-2 |
GO:0042696 | menarche | 2.102865e-2 |
GO:0006084 | acetyl-CoA metabolic process | 2.125110e-2 |
GO:0044070 | regulation of anion transport | 2.157397e-2 |
GO:0016142 | O-glycoside catabolic process | 2.160792e-2 |
GO:0050983 | deoxyhypusine biosynthetic process from spermidine, using deoxyhypusine synthase | 2.160792e-2 |
GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation | 2.160792e-2 |
GO:0045833 | negative regulation of lipid metabolic process | 2.169408e-2 |
GO:0009152 | purine ribonucleotide biosynthetic process | 2.208664e-2 |
GO:0008624 | induction of apoptosis by extracellular signals | 2.222325e-2 |
GO:0060350 | endochondral bone morphogenesis | 2.224709e-2 |
GO:0016265 | death | 2.254321e-2 |
GO:0070230 | positive regulation of lymphocyte apoptosis | 2.261308e-2 |
GO:0009166 | nucleotide catabolic process | 2.291514e-2 |
GO:0042119 | neutrophil activation | 2.294904e-2 |
GO:0072134 | nephrogenic mesenchyme morphogenesis | 2.304060e-2 |
GO:0060709 | glycogen cell development involved in embryonic placenta development | 2.304060e-2 |
GO:0046185 | aldehyde catabolic process | 2.304060e-2 |
GO:0032481 | positive regulation of type I interferon production | 2.313687e-2 |
GO:0021795 | cerebral cortex cell migration | 2.325001e-2 |
GO:0015804 | neutral amino acid transport | 2.347261e-2 |
GO:0072523 | purine-containing compound catabolic process | 2.364609e-2 |
GO:0008612 | peptidyl-lysine modification to hypusine | 2.368950e-2 |
GO:0002331 | pre-B cell allelic exclusion | 2.368950e-2 |
GO:0019543 | propionate catabolic process | 2.391399e-2 |
GO:0007617 | mating behavior | 2.409435e-2 |
GO:0070100 | negative regulation of chemokine-mediated signaling pathway | 2.445492e-2 |
GO:0045750 | positive regulation of S phase of mitotic cell cycle | 2.445492e-2 |
GO:0003157 | endocardium development | 2.454811e-2 |
GO:0014037 | Schwann cell differentiation | 2.466834e-2 |
GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment | 2.584836e-2 |
GO:0010948 | negative regulation of cell cycle process | 2.589685e-2 |
GO:0006270 | DNA-dependent DNA replication initiation | 2.655566e-2 |
GO:0090096 | positive regulation of metanephric cap mesenchymal cell proliferation | 2.655792e-2 |
GO:0090185 | negative regulation of kidney development | 2.655792e-2 |
GO:0051124 | synaptic growth at neuromuscular junction | 2.655792e-2 |
GO:0010511 | regulation of phosphatidylinositol biosynthetic process | 2.655792e-2 |
GO:0051081 | nuclear envelope disassembly | 2.655792e-2 |
GO:0008608 | attachment of spindle microtubules to kinetochore | 2.655792e-2 |
GO:0021759 | globus pallidus development | 2.655792e-2 |
GO:0045620 | negative regulation of lymphocyte differentiation | 2.675322e-2 |
GO:0050854 | regulation of antigen receptor-mediated signaling pathway | 2.690349e-2 |
GO:2000377 | regulation of reactive oxygen species metabolic process | 2.699887e-2 |
GO:0006900 | membrane budding | 2.712484e-2 |
GO:0006888 | ER to Golgi vesicle-mediated transport | 2.715826e-2 |
GO:0009206 | purine ribonucleoside triphosphate biosynthetic process | 2.725160e-2 |
GO:0006491 | N-glycan processing | 2.801187e-2 |
GO:0070536 | protein K63-linked deubiquitination | 2.808665e-2 |
GO:0046504 | glycerol ether biosynthetic process | 2.808665e-2 |
GO:0000381 | regulation of alternative nuclear mRNA splicing, via spliceosome | 2.835736e-2 |
GO:0015980 | energy derivation by oxidation of organic compounds | 2.852903e-2 |
GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production | 2.869350e-2 |
GO:0021569 | rhombomere 3 development | 2.869350e-2 |
GO:0060466 | activation of meiosis involved in egg activation | 2.869350e-2 |
GO:0034110 | regulation of homotypic cell-cell adhesion | 2.877588e-2 |
GO:0072239 | metanephric glomerulus vasculature development | 2.877588e-2 |